Latest Breaking News On - Educe covid hospitalisation risk - Page 1 : vimarsana.com

Fluvoxamine, which is currently used to treat mental health conditions, was chosen for study as a potential treatment for COVID-19 due to its anti-inflammatory properties.

Otavio berwangerAngela reiersenProfessor at washington universityMcmaster universityLancet global healthWorld health organisationAssociate professorWashington universityEdward millsEssential medicinesAcademic research organisationHospital israelita albert einsteinCovid 19Covid hospitalisationCovid 19 treatmentEduce covid hospitalisation risk